These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 14520462)

  • 1. GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON.
    Hoskin PJ; Sibtain A; Daley FM; Wilson GD
    Br J Cancer; 2003 Oct; 89(7):1290-7. PubMed ID: 14520462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding.
    Airley RE; Loncaster J; Raleigh JA; Harris AL; Davidson SE; Hunter RD; West CM; Stratford IJ
    Int J Cancer; 2003 Mar; 104(1):85-91. PubMed ID: 12532423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison between pimonidazole binding, oxygen electrode measurements, and expression of endogenous hypoxia markers in cancer of the uterine cervix.
    Jankovic B; Aquino-Parsons C; Raleigh JA; Stanbridge EJ; Durand RE; Banath JP; MacPhail SH; Olive PL
    Cytometry B Clin Cytom; 2006 Mar; 70(2):45-55. PubMed ID: 16456867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.
    Tan EY; Yan M; Campo L; Han C; Takano E; Turley H; Candiloro I; Pezzella F; Gatter KC; Millar EK; O'Toole SA; McNeil CM; Crea P; Segara D; Sutherland RL; Harris AL; Fox SB
    Br J Cancer; 2009 Jan; 100(2):405-11. PubMed ID: 19165203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression.
    Sowa T; Menju T; Chen-Yoshikawa TF; Takahashi K; Nishikawa S; Nakanishi T; Shikuma K; Motoyama H; Hijiya K; Aoyama A; Sato T; Sonobe M; Harada H; Date H
    Cancer Med; 2017 Jan; 6(1):288-297. PubMed ID: 28028936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible factor 1alpha expression as an intrinsic marker of hypoxia: correlation with tumor oxygen, pimonidazole measurements, and outcome in locally advanced carcinoma of the cervix.
    Hutchison GJ; Valentine HR; Loncaster JA; Davidson SE; Hunter RD; Roberts SA; Harris AL; Stratford IJ; Price PM; West CM
    Clin Cancer Res; 2004 Dec; 10(24):8405-12. PubMed ID: 15623619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CAIX and CAXII Expression in Breast Cancer at Varied O2 Levels: CAIX is the Superior Surrogate Imaging Biomarker of Tumor Hypoxia.
    Tafreshi NK; Lloyd MC; Proemsey JB; Bui MM; Kim J; Gillies RJ; Morse DL
    Mol Imaging Biol; 2016 Apr; 18(2):219-31. PubMed ID: 26276155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stromal expression of hypoxia regulated proteins is an adverse prognostic factor in colorectal carcinomas.
    Cleven AH; van Engeland M; Wouters BG; de Bruïne AP
    Cell Oncol; 2007; 29(3):229-40. PubMed ID: 17452775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pattern of CAIX expression is prognostic for outcome and predicts response to ARCON in patients with laryngeal cancer treated in a phase III randomized trial.
    Rademakers SE; Hoogsteen IJ; Rijken PF; Oosterwijk E; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende P; Takes R; De Bree R; van der Kogel AJ; Bussink J; Kaanders JH
    Radiother Oncol; 2013 Sep; 108(3):517-22. PubMed ID: 23719582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverging prognostic impacts of hypoxic markers according to NSCLC histology.
    Andersen S; Eilertsen M; Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
    Lung Cancer; 2011 Jun; 72(3):294-302. PubMed ID: 21075472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4.
    Rademakers SE; Lok J; van der Kogel AJ; Bussink J; Kaanders JH
    BMC Cancer; 2011 May; 11():167. PubMed ID: 21569415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia and metabolic phenotypes during breast carcinogenesis: expression of HIF-1alpha, GLUT1, and CAIX.
    Chen CL; Chu JS; Su WC; Huang SC; Lee WY
    Virchows Arch; 2010 Jul; 457(1):53-61. PubMed ID: 20526721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of hypoxia-inducible factor-1α predicts benefit from hypoxia modification in invasive bladder cancer.
    Hunter BA; Eustace A; Irlam JJ; Valentine HR; Denley H; Oguejiofor KK; Swindell R; Hoskin PJ; Choudhury A; West CM
    Br J Cancer; 2014 Jul; 111(3):437-43. PubMed ID: 24937673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of the proliferation marker Ki-67 in laryngeal carcinoma: results of the accelerated radiotherapy with carbogen breathing and nicotinamide phase III randomized trial.
    Rademakers SE; Hoogsteen IJ; Rijken PF; Terhaard CH; Doornaert PA; Langendijk JA; van den Ende P; van der Kogel AJ; Bussink J; Kaanders JH
    Head Neck; 2015 Feb; 37(2):171-6. PubMed ID: 24347430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Hypoxia-inducible factor-1 α , glucose transporter-1, (GLUT-1) and carbon anhydrase IX in endometrial cancer patients.
    Sadlecki P; Bodnar M; Grabiec M; Marszalek A; Walentowicz P; Sokup A; Zegarska J; Walentowicz-Sadlecka M
    Biomed Res Int; 2014; 2014():616850. PubMed ID: 24745019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX.
    Korkolopoulou P; Perdiki M; Thymara I; Boviatsis E; Agrogiannis G; Kotsiakis X; Angelidakis D; Rologis D; Diamantopoulou K; Thomas-Tsagli E; Kaklamanis L; Gatter K; Patsouris E
    Hum Pathol; 2007 Apr; 38(4):629-38. PubMed ID: 17367605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
    Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
    Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-L1 protein expression in non-small-cell lung cancer and its relationship with the hypoxia-related signaling pathways: A study based on immunohistochemistry and RNA sequencing data.
    Koh YW; Lee SJ; Han JH; Haam S; Jung J; Lee HW
    Lung Cancer; 2019 Mar; 129():41-47. PubMed ID: 30797490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble form of carbonic anhydrase IX (CAIX) in transitional cell carcinoma of urinary tract.
    Hyrsl L; Zavada J; Zavadova Z; Kawaciuk I; Vesely S; Skapa P
    Neoplasma; 2009; 56(4):298-302. PubMed ID: 19473055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of endogenous hypoxia-related markers for head and neck squamous cell carcinomas treated with ARCON.
    Jonathan RA; Wijffels KI; Peeters W; de Wilde PC; Marres HA; Merkx MA; Oosterwijk E; van der Kogel AJ; Kaanders JH
    Radiother Oncol; 2006 Jun; 79(3):288-97. PubMed ID: 16730088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.